China Pharma Holdings (CPHI) Depreciation and Depletion (2016 - 2026)
China Pharma Holdings (CPHI) posted Depreciation and Depletion of $155288.0 for Q1 2026, up 159.13% on a QoQ basis from $59927.0 in Q4 2025, and down 9.51% year-over-year from $171601.0 in Q1 2025.
China Pharma Holdings (CPHI) Depreciation and Depletion (2016 - 2026) Analysis & Trends
China Pharma Holdings' Depreciation and Depletion history runs 11 years deep, the most recent figure standing at $155288.0 for Q1 2026.
- Quarterly Depreciation and Depletion fell 9.51% year-over-year to $155288.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $536794.0 (down 66.64% YoY) and the FY2025 annual result came in at $652026.0, down 69.96% from the prior year.
- Depreciation and Depletion was $155288.0 for Q1 2026 at China Pharma Holdings, up from $59927.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $673931.0 in Q1 2022 and bottomed at $59927.0 in Q4 2025.
- A 5-year average of $467449.6 and a median of $630579.0 in 2023 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2024 — Depreciation and Depletion grew 1.92% — and 2025, when it sank 80.53%.
- China Pharma Holdings' Depreciation and Depletion stood at $630781.0 in 2022, then climbed by 0.44% to $633577.0 in 2023, then sank by 51.43% to $307741.0 in 2024, then tumbled by 80.53% to $59927.0 in 2025, then soared by 159.13% to $155288.0 in 2026.
- Business Quant data shows CPHI's Depreciation and Depletion at $155288.0 in Q1 2026, $59927.0 in Q4 2025, and $158076.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | 155,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 155,288.00 |
| Mar 31, 2026 | 155,288.00 |
| Dec 31, 2025 | 59,927.00 |
| Dec 31, 2025 | 59,927.00 |
| Sep 30, 2025 | 158,076.00 |
| Sep 30, 2025 | 158,076.00 |
| Jun 30, 2025 | 163,503.00 |
| Jun 30, 2025 | 163,503.00 |
| Mar 31, 2025 | 171,601.00 |
| Mar 31, 2025 | 171,601.00 |
| Dec 31, 2024 | 307,741.00 |
| Dec 31, 2024 | 307,741.00 |
| Sep 30, 2024 | 493,180.00 |
| Sep 30, 2024 | 493,180.00 |
| Jun 30, 2024 | 636,721.00 |
| Jun 30, 2024 | 636,721.00 |
| Mar 31, 2024 | 636,721.00 |
| Mar 31, 2024 | 636,721.00 |
| Dec 31, 2023 | 633,577.00 |
| Dec 31, 2023 | 633,577.00 |